A case of chronic myelogenous leukemia with the T315I mutation who progressed to myeloid blast phase and was successfully treated with asciminib.

Tomassetti, Sarah; Lee, Jennifer; Qing, Xin

Tomassetti, Sarah; Lee, Jennifer; Qing, Xin.

Afiliación

Tomassetti S; Division of Hematology and Oncology Harbor-UCLA Medical Center and The David Geffen School of Medicine at UCLA Los Angeles California USA.
Lee J; The Lundquist Research Institute Torrance California USA.
Qing X; Division of Hematology and Oncology Harbor-UCLA Medical Center and The David Geffen School of Medicine at UCLA Los Angeles California USA.

Clin Case Rep ; 10(11): e6478, 2022 Nov.

Article en En | MEDLINE | ID: mdl-36381034

Palabras clave

T315I mutation; asciminib; blast phase; chronic myelogenous leukemia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Clin Case Rep Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google